New Rules Threaten AbbVie's Shire Deal

Pharmaceutical giant AbbVie said it was re-evaluating its planned $54 billion acquisition of Shire in light of new U.S. rules making it harder for American companies to lower taxes through overseas deal making.



from WSJ.com: US Business http://ift.tt/1qqk8WB

via IFTTT